TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/25/24 16:03 | 3/22/24 | IMRX | Immuneering Corp | DE | Health | Drug | Pharmaceutical Preparations | Schall Thomas J. | MA | D | P | 7 | 2.55 | 0 | 3 | New | 3 | D | |||||||||||||||
8/8/22 19:41 | 8/4/22 | CCXI | Chemocentryx, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schall Thomas J. | CA | DO | P,CEO | M.d | 1,856 | 14.28 | 0 | 130 | 6 | 2,393 | D | ||||||||||||||
8/8/22 19:41 | 8/4/22 | CCXI | Chemocentryx, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schall Thomas J. | CA | DO | P,CEO | S.d | -6,532 | 50.24 | 0 | -130 | -5 | 2,393 | D | ||||||||||||||
1/4/22 21:42 | 1/1/22 | CCXI | Chemocentryx, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schall Thomas J. | CA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 84 | 4 | 2,393 | D | ||||||||||||||
12/3/21 19:39 | 12/1/21 | CCXI | Chemocentryx, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schall Thomas J. | CA | DO | P,CEO | M.d | 500 | 10.88 | 0 | 46 | 2 | 2,355 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |